Isunakinra is under clinical development by Buzzard Pharmaceuticals and currently in Phase II for Pancreatic Cancer.

MCLA-145 is under clinical development by Merus and currently in Phase I for Urethral Cancer. According to GlobalData, Phase I drugs for Urethral Cancer does not have sufficient historical data to ...

Pancreatic cancer can often be halted, but it's rarely detected in time.The largest gland in the human body produces enzymes and hormones that are vital for digestion and metabolism. However, it is ...